Xiangyang Zu

832 total citations
27 papers, 627 citations indexed

About

Xiangyang Zu is a scholar working on Biomedical Engineering, Pharmacology and Molecular Biology. According to data from OpenAlex, Xiangyang Zu has authored 27 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomedical Engineering, 7 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Xiangyang Zu's work include Microbial Natural Products and Biosynthesis (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Antimicrobial Peptides and Activities (3 papers). Xiangyang Zu is often cited by papers focused on Microbial Natural Products and Biosynthesis (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Antimicrobial Peptides and Activities (3 papers). Xiangyang Zu collaborates with scholars based in China, United States and Russia. Xiangyang Zu's co-authors include Jinghua Li, Zhigang Hu, Pengchao Zhao, Gengfu Xiao, Xuefei Bai, Zheng Zhou, Kena Song, Haibin Liu, Shaobo Wang and Wei Wang and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Xiangyang Zu

26 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyang Zu China 16 180 177 99 99 77 27 627
Marcelo Lancellotti Brazil 21 306 1.7× 152 0.9× 48 0.5× 114 1.2× 153 2.0× 65 1.1k
Fazren Azmi Malaysia 12 309 1.7× 89 0.5× 63 0.6× 65 0.7× 85 1.1× 27 658
Rodrigo V. Portugal Brazil 20 453 2.5× 164 0.9× 46 0.5× 49 0.5× 126 1.6× 53 992
Yanping Jiang China 16 478 2.7× 155 0.9× 35 0.4× 71 0.7× 107 1.4× 53 1.1k
Germana Lentini Italy 15 181 1.0× 134 0.8× 102 1.0× 46 0.5× 62 0.8× 31 640
Pierre Legras France 20 297 1.6× 101 0.6× 55 0.6× 408 4.1× 51 0.7× 29 1.4k
Alberto Danielli Italy 24 467 2.6× 169 1.0× 84 0.8× 95 1.0× 185 2.4× 49 1.3k
Stefano Agnello Italy 16 229 1.3× 100 0.6× 20 0.2× 77 0.8× 26 0.3× 32 650
Amir M. Farnoud United States 20 421 2.3× 105 0.6× 33 0.3× 210 2.1× 63 0.8× 42 916
Chean Yeah Yong Malaysia 15 316 1.8× 153 0.9× 59 0.6× 251 2.5× 51 0.7× 37 976

Countries citing papers authored by Xiangyang Zu

Since Specialization
Citations

This map shows the geographic impact of Xiangyang Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Zu more than expected).

Fields of papers citing papers by Xiangyang Zu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyang Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Zu. The network helps show where Xiangyang Zu may publish in the future.

Co-authorship network of co-authors of Xiangyang Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyang Zu. A scholar is included among the top collaborators of Xiangyang Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyang Zu. Xiangyang Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jing, Wenqian Zhao, Xiangyang Zu, et al.. (2025). Magnetic vortex iron oxide nanorings coated with mesoporous silica as smart diagnostic and therapeutic nanoagents: Negative MRI-guided tumor magnetothermal-chemotherapy. Materials Today Communications. 44. 111966–111966. 2 indexed citations
2.
3.
Guo, Tengfei, Tao Jiang, Zhanqin Zhao, et al.. (2022). Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis. BMC Infectious Diseases. 22(1). 812–812. 2 indexed citations
4.
Bao, Jianfeng, Xiangyang Zu, Dandan Fan, et al.. (2022). Magnetic vortex nanoring coated with gadolinium oxide for highly enhanced T1-T2 dual-modality magnetic resonance imaging-guided magnetic hyperthermia cancer ablation. Biomedicine & Pharmacotherapy. 150. 112926–112926. 13 indexed citations
5.
Song, Kena, et al.. (2022). Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment. International Journal of Molecular Sciences. 23(18). 10509–10509. 54 indexed citations
6.
Song, Kena, et al.. (2021). Diversity Models and Applications of 3D Breast Tumor-on-a-Chip. Micromachines. 12(7). 814–814. 15 indexed citations
7.
Li, Zhao, Xiangyang Zu, Zhe Du, & Zhigang Hu. (2021). Research on magnetic bead motion characteristics based on magnetic beads preset technology. Scientific Reports. 11(1). 19995–19995. 12 indexed citations
8.
Bao, Jianfeng, Xiangyang Zu, Xiao Wang, et al.. (2020). <p>Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy</p>. International Journal of Nanomedicine. Volume 15. 7687–7702. 65 indexed citations
9.
10.
Wang, Mengya, Xiangyang Zu, Zhanqin Zhao, et al.. (2020). Cephalosporin Resistance in Escherichia coli Isolated from Children with Septicemia in Mainland China from 2007 to 2017: A Systematic Review and Meta-Analysis. Microbial Drug Resistance. 26(10). 1250–1259. 5 indexed citations
11.
Zhao, Pengchao, Xin Li, Jinghua Li, et al.. (2019). Fungi-derived lipopeptide antibiotics developed since 2000. Peptides. 113. 52–65. 40 indexed citations
12.
Zhang, Yanjun, Zheng Zhou, Xiangyang Zu, et al.. (2019). A novel RSV F-Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection. Antiviral Research. 165. 11–22. 18 indexed citations
13.
Zhao, Pengchao, Jinghua Li, Xin Li, et al.. (2019). Non-lipopeptide fungi-derived peptide antibiotics developed since 2000. Biotechnology Letters. 41(6-7). 651–673. 20 indexed citations
14.
Xue, Yun, Mengya Wang, Pengchao Zhao, et al.. (2018). Gram-negative bacilli-derived peptide antibiotics developed since 2000. Biotechnology Letters. 40(9-10). 1271–1287. 13 indexed citations
15.
Zhao, Pengchao, Weina Gao, Jinghua Li, et al.. (2018). Actinobacteria –Derived peptide antibiotics since 2000. Peptides. 103. 48–59. 45 indexed citations
16.
Li, Jinghua, Xiangyang Zu, Gaofeng Liang, et al.. (2018). Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy. Theranostics. 8(4). 1042–1058. 35 indexed citations
17.
Zhao, Pengchao, Weina Gao, Jinghua Li, et al.. (2017). Bacillaceae -derived peptide antibiotics since 2000. Peptides. 101. 10–16. 58 indexed citations
18.
Wang, Shaobo, Haibin Liu, Xiangyang Zu, et al.. (2016). The ubiquitin-proteasome system is essential for the productive entry of Japanese encephalitis virus. Virology. 498. 116–127. 43 indexed citations
19.
Zu, Xiangyang, Yang Liu, Shaobo Wang, et al.. (2014). Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. Antiviral Research. 104. 7–14. 38 indexed citations
20.
Wang, Wei, Yang Liu, Xiangyang Zu, Rui Jin, & Gengfu Xiao. (2011). Blocking peptides against HBV: PreS1 protein selected from a phage display library. Biochemical and Biophysical Research Communications. 412(4). 633–637. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo Lancellotti Breakdown of academic impact, for papers by Fazren Azmi Breakdown of academic impact, for papers by Rodrigo V. Portugal Breakdown of academic impact, for papers by Yanping Jiang Breakdown of academic impact, for papers by Germana Lentini Breakdown of academic impact, for papers by Pierre Legras Breakdown of academic impact, for papers by Alberto Danielli Breakdown of academic impact, for papers by Stefano Agnello Breakdown of academic impact, for papers by Amir M. Farnoud Breakdown of academic impact, for papers by Chean Yeah Yong
Rankless by CCL
2026